Johnson & Johnson’s recall of children’s medicines may cost $200 million to $300 million, according to Chief Financial Officer Dominic Caruso. The estimated cost suggested by analysts “is not unreasonable,” Caruso said Tuesday at the Bank of America Merrill Lynch Health Care Conference in New York. The New Brunswick-based company is still investigating the contamination at a manufacturing plant that led to the recall and doesn’t know when the issue will be resolved, he said. (If you’ve purchased a bottle which is on the recall list, click here to view a previously posted article on how to obtain a refund). Bloomberg.